Related Experiment Video
Updated: Jul 3, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Asthma 2008: targeting immunoglobulin E to achieve disease control
1Allergy Associates Medical Group, Inc, San Diego, California 92120, USA. prenner@aaamg.com
Summary
Regularly assessing asthma control is key for managing moderate-to-severe cases. Omalizumab, a biologic therapy targeting immunoglobulin E (IgE), effectively reduces exacerbations and improves symptoms in patients with IgE-mediated asthma.
Area of Science:
- Allergy and Immunology
- Pulmonology
- Pharmacology
Background:
- Traditional asthma guidelines recommend step-wise treatment based on severity.
- Many patients with moderate-to-severe asthma remain uncontrolled despite aggressive therapy.
- Current guidelines emphasize regular assessment of asthma control (impairment and risk).
Purpose of the Study:
- To evaluate the effectiveness of omalizumab in patients with moderate-to-severe IgE-mediated asthma.
- To highlight the shift towards asthma control assessment in treatment decisions.
- To present omalizumab as an enhanced treatment option for persistent asthma.
Main Methods:
- Review of evidence on the role of immunoglobulin E (IgE) in asthma.
- Analysis of randomized controlled studies on omalizumab efficacy.
- Assessment of omalizumab's impact on asthma exacerbations, lung function, and symptoms.
Main Results:
- Omalizumab significantly reduced asthma exacerbations in inadequately controlled patients.
- Improved lung function and symptoms were observed with omalizumab treatment.
- Benefits were maintained during inhaled corticosteroid dose reduction.
Conclusions:
- Omalizumab is an effective treatment for moderate-to-severe IgE-mediated asthma.
- Blocking IgE with omalizumab addresses airway inflammation and improves asthma control.
- Omalizumab is well-tolerated, with rare anaphylactic reactions requiring monitoring.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...